Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wells Fargo maintains underweight lowers target to $111
Deutsche Bank maintains hold, lowers target to $121
$ZBH Needham analyst Mike Matson maintains Zimmer Biomet Holdings with a Buy and lowers the price target from $155 to $143
$ZBH SVB Leerink analyst Danielle Antalffy maintains Zimmer Biomet Holdings with a Outperform and lowers the price target from $150 to $135
$ZBH Canaccord Genuity analyst Kyle Rose downgrades Zimmer Biomet Holdings from Buy to Hold and lowers the price target from $165 to $125
$ZBH Piper Sandler from $135.00 to $110.00
2/7 Monday's close 111.67
It's unclear with just headline analyst target's if it includes ZimVie or without ZimVie
to repeat
Zimmer Biomet shareholders of record as of the close of business on February 15, 2022 (the "Record Date"). The dividend is payable at 12:01 a.m. ET on March 1, 2022 (the "Distribution Date"). As a result of the dividend, Zimmer Biomet shareholders will receive one share of ZimVie common stock for every ten shares of Zimmer Biomet common stock they hold on the Record Date.
This is ZBH’s biggest biz-dev transaction since the merger of Zimmer and Biomet in 2015.
ZIMV 2022 non-GAAP EPS guidance=$2.10-2.30:
https://finance.yahoo.com/news/zimvie-hosts-inaugural-investor-day-141500225.html
ZBH -7% because of soft 2022 guidance announced with 4Q21 results:
https://finance.yahoo.com/news/zimmer-biomet-announces-fourth-quarter-113000363.html
ZBH PR/slides re ZimVie (ZIMV) spinoff:
https://www.prnewswire.com/news-releases/zimmer-biomet-announces-expected-completion-date-of-march-1-2022-for-spinoff-of-zimvie-301476209.html
https://78449.choruscall.com/dataconf/productusers/zbh/media/2022/zbh220207_1100_presentation.pdf
Zimmer Biomet Holdings Inc (ZBH) Q3 2021 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2021/11/04/zimmer-biomet-holdings-inc-zbh-q3-2021-earnings-ca/
Zimmer Biomet Holdings Inc (ZBH) Q2 2021 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2021/08/03/zimmer-biomet-holdings-inc-zbh-q2-2021-earnings-ca/
Someones gotta post this.
ZBH 2Q21 sales_flat–to-slightly-down_vs_2Q19—(way up vs pandemic 2Q20):
https://finance.yahoo.com/news/zimmer-biomet-announces-second-quarter-103000408.html
Updated 2021 full-year non-GAAP EPS guidance is $7.65-7.95 (narrowed from $7.60-8.00).
Zimmer Biomet Holdings Inc (ZBH) Q1 2021 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2021/05/04/zimmer-biomet-holdings-inc-zbh-q1-2021-earnings-ca/
ZBH issues_2021_guidance—>12.5-15.5%_YoY_revenue_growth_in_constant_currency:
https://investor.zimmerbiomet.com/~/media/Files/Z/ZimmerBiomet-IR/press-release/q1-2021-earnings-release.pdf
Zimmer Biomet Holdings Inc (ZBH) Q4 2020 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2021/02/05/zimmer-biomet-holdings-inc-zbh-q4-2020-earnings-ca/
The stock is +5% in PM trading. Investors are suckers for spin-offs.
ZBH to spin-off dental/spine businesses—(two losers):
https://finance.yahoo.com/news/zimmer-biomet-announces-intent-spin-113100667.html
The spin-off company has yet to be named. Deal closing is targeted for mid-2022. The deal is tax-free for ZBH shareholders.
ZBH 4Q20 results—no 2021 guidance due to COVID:
https://investor.zimmerbiomet.com/news-and-events/news/2021/02-05-2021-113032509
Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q3 2020 Results - Earnings Call Transcript
https://www.google.com/amp/s/seekingalpha.com/amp/article/4386109-zimmer-biomet-holdings-inc-zbh-ceo-bryan-hanson-on-q3-2020-results-earnings-call-transcript
ZBH_3Q20_results—no_4Q20_guidance_due_to_COVID:
https://finance.yahoo.com/m/62919b99-2139-3ee7-a0dd-02f484b7d7ec/3-reasons-pfizer-s-imminent.html
Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q2 2020 Results - Earnings Call Transcript
https://seekingalpha.com/article/4364273-zimmer-biomet-holdings-inc-zbh-ceo-bryan-hanson-on-q2-2020-results-earnings-call-transcript
ZBH—(-4%)—declines to reinstate 2020 guidance (which was withdrawn on 4/6/20):
https://investor.zimmerbiomet.com/~/media/Files/Z/ZimmerBiomet-IR/press-release/q1-2020-earnings-release.pdf
ZBH quantifies the damage—in part:
https://www.prnewswire.com/news-releases/zimmer-biomet-provides-update-on-covid-19-impact-301036176.html
$ZBH bears and bulls Zimmer Biomet Holdings Inc Nyse Zbh Short Squeeze
ZBH 3Q19 CC transcript:
https://finance.yahoo.com/news/edited-transcript-zbh-earnings-conference-230128346.html
Edited Transcript of ZBH earnings conference call or presentation 26-Jul-19 12:30pm GMT
https://finance.yahoo.com/news/edited-transcript-zbh-earnings-conference-122100216.html
News: $ZBH Zimmer Biomet Announces Second Quarter 2019 Financial Results
WARSAW, Ind. , July 26, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended June 30, 2019. The Company reported second quarter net sales of $1.989 billion , a decrease of 0.9% from the prior year per...
Got this from Zimmer Biomet Announces Second Quarter 2019 Financial Results
Zimmer Biomet Holdings (ZBH) Q1 2019 Earnings Call Transcript
https://finance.yahoo.com/news/zimmer-biomet-holdings-zbh-q1-232013416.html
Syed Jafry bought just under 2k shares at 125.52 on 3/1 open market. He and Hilado, who also recently bought on open market, were added to Zimmer's board back in August.
https://www.sec.gov/Archives/edgar/data/1136869/000091191619000068/xslF345X03/edgar.xml
The amounts are not huge, but you don't often see so many insiders buying at the same time.
Six ZBH insiders cumulatively bought~$2M of stock on the open market…
CEO ($240K):
https://www.sec.gov/Archives/edgar/data/1136869/000091191619000026/xslF345X03/edgar.xml
Director ($500K):
https://www.sec.gov/Archives/edgar/data/1136869/000091191619000020/xslF345X03/edgar.xml
Director ($240K):
https://www.sec.gov/Archives/edgar/data/1136869/000091191619000018/xslF345X03/edgar.xml
Director ($300K):
https://www.sec.gov/Archives/edgar/data/1136869/000091191619000022/xslF345X03/edgar.xml
Director ($250K):
https://www.sec.gov/Archives/edgar/data/1136869/000091191619000024/xslF345X03/edgar.xml
Director ($200K):
https://www.sec.gov/Archives/edgar/data/1136869/000091191619000024/xslF345X03/edgar.xml
News: $ZBH Zimmer Biomet Receives FDA Clearance for ROSA® Knee System for Robotically-Assisted Surgeries
WARSAW, Ind. , Jan. 25, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510(k) clearance of the ROSA ® Knee System for robotically-assisted total knee replacement ...
Find out more https://marketwirenews.com/news-releases/zimmer-biomet-receives-fda-clearance-for-rosa-xae-knee-system-for-robotically-assisted-surgeries-7555322.html
Zimmer Biomet Holdings Inc (ZBH) Q3 2018 Earnings Conference Call Transcript
https://www.yahoo.com/amphtml/finance/news/zimmer-biomet-holdings-inc-zbh-171926622.html
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2018 Earnings Conference Call Transcript
https://www.yahoo.com/amphtml/finance/news/zimmer-biomet-holdings-inc-zbh-142000184.html
Zimmer Biomet Q4'17 Edited Conference Call
https://finance.yahoo.com/news/edited-transcript-zbh-earnings-conference-063938591.html
Zimmer Biomet Q1'18 Edited Conference Call
https://finance.yahoo.com/news/edited-transcript-zbh-earnings-conference-123747254.html
ZBH 2Q17 CC (edited) transcript:
https://finance.yahoo.com/news/edited-transcript-zbh-earnings-conference-215043004.html
Barron's Roundtable participant likes ZBH: #msg-128046924.
$ZMH DD Notes ~ http://www.ddnotesmaker.com/ZMH
bullish
$ZMH recent news/filings
## source: finance.yahoo.com
Fri, 26 Dec 2014 18:20:57 GMT ~ Midday Glance: Medical Devices companies
read full: http://sg.finance.yahoo.com/news/midday-glance-medical-devices-companies-183358924.html
*********************************************************
Fri, 26 Dec 2014 15:23:18 GMT ~ Early Glance: Medical Devices companies
read full: http://sg.finance.yahoo.com/news/early-glance-medical-devices-companies-142638361--finance.html
*********************************************************
Wed, 24 Dec 2014 23:02:19 GMT ~ Final Glance: Medical Devices companies
read full: http://sg.finance.yahoo.com/news/final-glance-medical-devices-companies-230331175.html
*********************************************************
Fri, 19 Dec 2014 20:57:45 GMT ~ U.S. appeals court cuts damages Zimmer must pay Stryker
[Reuters] - A U.S. federal appeals court has slashed the damages that Zimmer Holdings Inc will have to pay Stryker Corp for infringing its patents on a surgical cleaning wand. The top U.S. patent court said on Friday ...
read full: http://finance.yahoo.com/news/u-appeals-court-cuts-damages-205745578.html
*********************************************************
Mon, 15 Dec 2014 14:21:44 GMT ~ Dec 15, 2014 Zimmer Holdings, Inc. Announces Quarterly Dividend for Fourth Quarter of 2014
[at noodls] - WARSAW, Ind., Dec. 15, 2014 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, today announced that its Board of Directors has approved the payment of a ...
read full: http://www.noodls.com/view/598F866D114707ECD0FADB017DF4ADF1E5B88B9E
*********************************************************
$ZMH charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ZMH company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ZMH/company-info
Ticker: $ZMH
OTC Market Place: Not Available
CIK code: 0001136869
Company name: Zimmer Holdings, Inc.
Incorporated In: DE, USA
$ZMH share structure
## source: otcmarkets.com
Market Value: $19,335,126,885 a/o Dec 26, 2014
Shares Outstanding: 169,353,831 a/o Oct 29, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$ZMH extra dd links
Company name: Zimmer Holdings, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ZMH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ZMH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ZMH+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ZMH/news - http://finance.yahoo.com/q/h?s=ZMH+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ZMH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ZMH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ZMH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ZMH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Zimmer+Holdings%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Zimmer+Holdings%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Zimmer+Holdings%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ZMH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001136869&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ZMH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ZMH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ZMH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ZMH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ZMH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ZMH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ZMH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ZMH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ZMH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ZMH+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ZMH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ZMH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ZMH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ZMH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ZMH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ZMH/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ZMH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ZMH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ZMH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ZMH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ZMH
$ZMH DD Notes ~ http://www.ddnotesmaker.com/ZMH
The performance in the last quarter was nothing special with slight decline in revenues and minor improvement in net income. Over the years also, the revenues and net income have not shown any substantial growth. Consequently, the growth in the stock has also been moderate and it has appreciated by less than 20% on a 52 week basis. It has corrected by 7% from its recent high of around $82. The dividends have not been consistent, and the yield is also around 1% only. Valuations remain reasonably attractive with a trailing P/E of around 17 and a forward P/E of around 12. The debt has shown some declines in last quarter. As on March 31, the debt was around $1.7 billion and cash was around $1.2 billion which indicates reasonably good liquidity position (current ratio of around 4.5). The key to success is good growth with expansion of margins. For this, the company has to bring out innovative products from time to time and also explore new markets. This is the key to success in pharmaceutical / medical devices companies, and even smaller companies like PLC Systems (PLCSF) have been building patents around their innovative proprietary technologies to improve future growth possibilities. Currently Zimmer's main market is US & Europe (82% of the revenues) while Asia Pacific contributes the rest. However, over the years emerging markets may grow faster and expand to increase their contribution to the sales. Many companies are concentrating on specific countries in the emerging markets for bolstering growth. As per a recent SA article, the medical device industry is expected to grow by 6.1% CAGR over the next few years ($302 billion in 2017). If Zimmer can take advantage of that, then it can shake of the sluggishness and improve future growth prospects. Innovative products will remain the key.
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
153
|
Created
|
08/11/12
|
Type
|
Free
|
Moderators DewDiligence |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |